Interaction of trivalent axsenicals with metallothionein

被引:98
作者
Jiang, GF
Gong, ZL
Li, XF
Cullen, WR
Le, XC [1 ]
机构
[1] Univ Alberta, Dept Publ Hlth Sci, Fac Med & Dent, Edmonton, AB T6G 2G3, Canada
[2] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada
关键词
D O I
10.1021/tx034053g
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Arsenic is a human carcinogen, causing skin, bladder, and lung cancers. Although arsenic in drinking water affects millions of people worldwide, the mechanism(s) of action by which arsenic causes cancers is not known. Arsenic probably exerts some toxic effects by binding with proteins. However, few experimental data are available on arsenic-containing proteins in biological systems. This study reports on arsenic interaction with metallothionein and established binding stoichiometries between metallothionein and the recently discovered trivalent metabolites of arsenic metabolism. Size exclusion chromatography with inductively coupled plasma mass spectrometry analysis of reaction mixtures between trivalent arsenicals and metallothionein clearly demonstrated the formation of complexes of arsenic with metallothionein. Analysis of the complexes using electrospray quadrupole time-of-flight tandem mass spectrometry revealed the detailed binding stoichiometry between arsenic and the 20 Cys residues in the metallothionein molecule. Inorganic arsenite (As-III) and its two trivalent methylation metabolites, monomethylarsonous acid (MMA(III)) and dimethylarsinous acid (DMA(III)), readily bind with metallothionein. Each metallothionein molecule could bind with up to six As-III, 10 MMA(III), and 20 DMA(III) molecules, consistent with the coordination chemistry of these arsenicals. The findings on arsenic interaction with proteins are useful for a better understanding of arsenic health effects.
引用
收藏
页码:873 / 880
页数:8
相关论文
共 62 条
[1]   Arsenic: Health effects, mechanisms of actions, and research issues [J].
Abernathy, CO ;
Liu, YP ;
Longfellow, D ;
Aposhian, HV ;
Beck, B ;
Fowler, B ;
Goyer, R ;
Menzer, R ;
Rossman, T ;
Thompson, C ;
Waalkes, M .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1999, 107 (07) :593-597
[2]  
[Anonymous], 1999, Arsenic in drinking water
[3]  
[Anonymous], 1996, CASARETT DOULLS TOXI
[4]   Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic [J].
Aposhian, HV ;
Gurzau, ES ;
Le, XC ;
Gurzau, A ;
Healy, SM ;
Lu, XF ;
Ma, MS ;
Yip, L ;
Zakharyan, RA ;
Maiorino, RM ;
Dart, RC ;
Tircus, MG ;
Gonzalez-Ramirez, D ;
Morgan, DL ;
Avram, D ;
Aposhian, MM .
CHEMICAL RESEARCH IN TOXICOLOGY, 2000, 13 (08) :693-697
[5]   Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity [J].
Aposhian, HV .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :397-419
[6]   Epidemiology - India's spreading health crisis draws global arsenic experts [J].
Bagla, P ;
Kaiser, J .
SCIENCE, 1996, 274 (5285) :174-175
[7]   The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects [J].
Bode, AM ;
Dong, ZG .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2002, 42 (01) :5-24
[8]   ARSENIC BINDING-PROTEINS OF MAMMALIAN SYSTEMS .1. ISOLATION OF 3 ARSENITE-BINDING PROTEINS OF RABBIT LIVER [J].
BOGDAN, GM ;
SAMPAYOREYES, A ;
APOSHIAN, HV .
TOXICOLOGY, 1994, 93 (2-3) :175-193
[9]  
Buchet J. P., 1994, P181
[10]   A new type of compound containing arsenic [J].
Burrows, GJ ;
Turner, EE .
JOURNAL OF THE CHEMICAL SOCIETY, 1920, 117 :1373-1383